ES2557805T3 - Liofilizacion de agente tensioactivo pulmonar liposomico sintetico - Google Patents
Liofilizacion de agente tensioactivo pulmonar liposomico sintetico Download PDFInfo
- Publication number
- ES2557805T3 ES2557805T3 ES13716655.9T ES13716655T ES2557805T3 ES 2557805 T3 ES2557805 T3 ES 2557805T3 ES 13716655 T ES13716655 T ES 13716655T ES 2557805 T3 ES2557805 T3 ES 2557805T3
- Authority
- ES
- Spain
- Prior art keywords
- temperature
- mixture
- lyophilization
- pulmonary surfactant
- solidified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/395—Alveolar surfactant peptides; Pulmonary surfactant peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0082—Lung surfactant, artificial mucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F26—DRYING
- F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
- F26B5/00—Drying solid materials or objects by processes not involving the application of heat
- F26B5/04—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum
- F26B5/06—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum the process involving freezing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261616827P | 2012-03-28 | 2012-03-28 | |
| US201261616827P | 2012-03-28 | ||
| PCT/US2013/034464 WO2013149074A1 (en) | 2012-03-28 | 2013-03-28 | Lyophilization of synthetic liposomal pulmonary surfactant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2557805T3 true ES2557805T3 (es) | 2016-01-28 |
Family
ID=48096305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES13716655.9T Active ES2557805T3 (es) | 2012-03-28 | 2013-03-28 | Liofilizacion de agente tensioactivo pulmonar liposomico sintetico |
Country Status (35)
| Country | Link |
|---|---|
| US (3) | US9554999B2 (OSRAM) |
| EP (2) | EP2837377A1 (OSRAM) |
| JP (1) | JP6178402B2 (OSRAM) |
| KR (1) | KR102123129B1 (OSRAM) |
| CN (1) | CN104271118B (OSRAM) |
| AU (2) | AU2013237985B2 (OSRAM) |
| BR (1) | BR112014024057A8 (OSRAM) |
| CA (1) | CA2867649C (OSRAM) |
| CL (1) | CL2014002553A1 (OSRAM) |
| CO (1) | CO7081146A2 (OSRAM) |
| CR (1) | CR20140449A (OSRAM) |
| CU (1) | CU20140116A7 (OSRAM) |
| CY (1) | CY1117380T1 (OSRAM) |
| DK (1) | DK2723323T3 (OSRAM) |
| EC (1) | ECSP14024363A (OSRAM) |
| ES (1) | ES2557805T3 (OSRAM) |
| HK (1) | HK1206979A1 (OSRAM) |
| HR (1) | HRP20151392T1 (OSRAM) |
| HU (1) | HUE026363T2 (OSRAM) |
| IL (1) | IL234688B (OSRAM) |
| IN (1) | IN2014DN08538A (OSRAM) |
| MA (1) | MA37445B1 (OSRAM) |
| MX (1) | MX359654B (OSRAM) |
| MY (1) | MY164868A (OSRAM) |
| NZ (1) | NZ630219A (OSRAM) |
| PE (1) | PE20142302A1 (OSRAM) |
| PL (1) | PL2723323T3 (OSRAM) |
| PT (1) | PT2723323E (OSRAM) |
| RS (1) | RS54513B1 (OSRAM) |
| RU (1) | RU2671500C2 (OSRAM) |
| SG (1) | SG11201405944PA (OSRAM) |
| SI (1) | SI2723323T1 (OSRAM) |
| SM (1) | SMT201500320B (OSRAM) |
| WO (2) | WO2013149013A1 (OSRAM) |
| ZA (1) | ZA201406982B (OSRAM) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2723323T3 (en) * | 2012-03-28 | 2016-01-11 | Discovery Lab Inc | FREEZE DRYING OF SYNTHETIC liposomal pulmonary surfactant |
| EP3222273B1 (en) * | 2014-11-18 | 2019-09-25 | National Institute for Materials Science | Method for producing porous particle |
| US10765753B2 (en) * | 2014-12-30 | 2020-09-08 | Samyang Biopharmaceuticals Corporation | Polymer nanoparticle freeze-dried product, and preparation method therefor |
| HUE053799T2 (hu) * | 2015-07-10 | 2021-07-28 | Byondis Bv | Antitest-duokarmicin gyógyszer-konjugátumokat tartalmazó készítmények |
| KR102716928B1 (ko) | 2015-07-22 | 2024-10-11 | 닛토덴코 가부시키가이샤 | 나노 입자 동결건조물 형태를 위한 조성물 및 방법 |
| JP7012512B2 (ja) * | 2017-11-13 | 2022-01-28 | 清水建設株式会社 | 管理装置、製造システムおよび管理方法 |
| WO2019126289A1 (en) * | 2017-12-21 | 2019-06-27 | Civitas Therapeutics, Inc. | Surfactant formulations for inhalation |
| CN108853061A (zh) * | 2018-10-09 | 2018-11-23 | 兆科药业（合肥）有限公司 | 一种人工合成肺表面活性剂药物组合物及与之的肠溶胶囊和其制备方法及用途 |
| WO2020142420A1 (en) * | 2018-12-31 | 2020-07-09 | Novus Therapeutics, Inc. | Novel surfactant-lipid alloy drug substance, methods of making the same, and pharmaceutical compositions comprising the same |
| US11287185B1 (en) | 2020-09-09 | 2022-03-29 | Stay Fresh Technology, LLC | Freeze drying with constant-pressure and constant-temperature phases |
| KR102545292B1 (ko) * | 2021-01-28 | 2023-06-16 | 인천대학교 산학협력단 | 마이크로캡슐 형성용 생체 적합 계면활성제 합성방법 |
| EP4366691A1 (en) * | 2021-07-05 | 2024-05-15 | Chiesi Farmaceutici S.p.A. | Process for the preparation of a pulmonary surfactant |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE751108R (fr) | 1969-06-06 | 1970-11-03 | Berliet Automobiles | Dispositif pour la mesure precise de la consommation specifiquedes moteurs a combustion |
| JPS59164724A (ja) * | 1983-03-10 | 1984-09-17 | Tokyo Tanabe Co Ltd | サ−フアクタント及びそれを含有する呼吸窮迫症候群治療剤 |
| US5260273A (en) * | 1988-01-06 | 1993-11-09 | The Scripps Research Institute | Pulmonary surfactant protein and related polypeptide |
| US6315983B1 (en) | 1996-01-24 | 2001-11-13 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Process for the production of powdered pulmonary surfactant preparations |
| AU2322097A (en) * | 1996-03-27 | 1997-10-17 | Ortho Pharmaceutical Corporation | Lyophilized pulmonary surfactant peptide compositions |
| US6652837B1 (en) | 1996-05-24 | 2003-11-25 | Massachusetts Institute Of Technology | Preparation of novel particles for inhalation |
| US5855913A (en) | 1997-01-16 | 1999-01-05 | Massachusetts Instite Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
| US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| JPWO2005105111A1 (ja) | 2004-04-29 | 2008-07-31 | 相男 李 | 人工肺サーファクタント組成物およびその使用方法 |
| US7582312B2 (en) * | 2004-11-15 | 2009-09-01 | Discovery Laboratories, Inc. | Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof |
| EP2377554A1 (en) | 2005-07-22 | 2011-10-19 | Amgen, Inc | Concentrated protein lyophilates, methods and uses |
| EP1997502A1 (en) | 2007-06-01 | 2008-12-03 | CHIESI FARMACEUTICI S.p.A. | Reconstituted surfactants having improved properties |
| DK2723323T3 (en) * | 2012-03-28 | 2016-01-11 | Discovery Lab Inc | FREEZE DRYING OF SYNTHETIC liposomal pulmonary surfactant |
-
2013
- 2013-03-28 DK DK13716655.9T patent/DK2723323T3/en active
- 2013-03-28 HR HRP20151392T patent/HRP20151392T1/hr unknown
- 2013-03-28 EP EP14188473.4A patent/EP2837377A1/en not_active Withdrawn
- 2013-03-28 PE PE2014001494A patent/PE20142302A1/es not_active Application Discontinuation
- 2013-03-28 RU RU2014143247A patent/RU2671500C2/ru active
- 2013-03-28 CA CA2867649A patent/CA2867649C/en active Active
- 2013-03-28 CN CN201380022948.0A patent/CN104271118B/zh active Active
- 2013-03-28 WO PCT/US2013/034364 patent/WO2013149013A1/en not_active Ceased
- 2013-03-28 NZ NZ630219A patent/NZ630219A/en not_active IP Right Cessation
- 2013-03-28 US US14/387,707 patent/US9554999B2/en active Active
- 2013-03-28 MY MYPI2014002699A patent/MY164868A/en unknown
- 2013-03-28 AU AU2013237985A patent/AU2013237985B2/en not_active Ceased
- 2013-03-28 SG SG11201405944PA patent/SG11201405944PA/en unknown
- 2013-03-28 HU HUE13716655A patent/HUE026363T2/en unknown
- 2013-03-28 PT PT137166559T patent/PT2723323E/pt unknown
- 2013-03-28 RS RS20150867A patent/RS54513B1/sr unknown
- 2013-03-28 IN IN8538DEN2014 patent/IN2014DN08538A/en unknown
- 2013-03-28 SI SI201330112T patent/SI2723323T1/sl unknown
- 2013-03-28 WO PCT/US2013/034464 patent/WO2013149074A1/en not_active Ceased
- 2013-03-28 JP JP2015503612A patent/JP6178402B2/ja active Active
- 2013-03-28 PL PL13716655T patent/PL2723323T3/pl unknown
- 2013-03-28 KR KR1020147029784A patent/KR102123129B1/ko active Active
- 2013-03-28 EP EP13716655.9A patent/EP2723323B1/en active Active
- 2013-03-28 ES ES13716655.9T patent/ES2557805T3/es active Active
- 2013-03-28 MX MX2014011483A patent/MX359654B/es active IP Right Grant
- 2013-03-28 BR BR112014024057A patent/BR112014024057A8/pt not_active Application Discontinuation
- 2013-11-27 US US14/091,712 patent/US8748397B2/en active Active
- 2013-11-27 US US14/091,608 patent/US8748396B2/en active Active
-
2014
- 2014-09-16 IL IL234688A patent/IL234688B/en active IP Right Grant
- 2014-09-25 ZA ZA2014/06982A patent/ZA201406982B/en unknown
- 2014-09-25 CL CL2014002553A patent/CL2014002553A1/es unknown
- 2014-09-25 CR CR20140449A patent/CR20140449A/es unknown
- 2014-09-29 CU CUP2014000116A patent/CU20140116A7/es unknown
- 2014-09-30 CO CO14216241A patent/CO7081146A2/es unknown
- 2014-10-22 MA MA37445A patent/MA37445B1/fr unknown
- 2014-10-24 EC ECIEPI201424363A patent/ECSP14024363A/es unknown
-
2015
- 2015-08-06 HK HK15107596.6A patent/HK1206979A1/en unknown
- 2015-12-21 SM SM201500320T patent/SMT201500320B/it unknown
- 2015-12-22 CY CY20151101180T patent/CY1117380T1/el unknown
-
2017
- 2017-10-06 AU AU2017239624A patent/AU2017239624B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2723323T3 (en) | FREEZE DRYING OF SYNTHETIC liposomal pulmonary surfactant | |
| ES2406764T3 (es) | Formulaciones que comprenden antagonistas de VEGF para administración intravítrea | |
| EP3082771B1 (en) | Compositions and methods for atmospheric spray freeze drying | |
| ES2401299T5 (es) | Formulaciones de caspofungina | |
| ES2408784T3 (es) | Preparaciones liofilizadas de HGF | |
| ES2648367T3 (es) | Procedimiento de preparación de una composición farmacéutica liofilizada que contiene mitomicina C | |
| ES2222700T3 (es) | Estructuras polimericas porosas para ingenieria tisular. | |
| JP6568846B2 (ja) | Ｈｇｆ凍結乾燥製剤 | |
| CN102512404A (zh) | 一种姜黄素类化合物肺靶向制剂及其制备方法与应用 | |
| SU978715A3 (ru) | Способ получени водного раствора простациклина или его соли | |
| JP2020522577A5 (OSRAM) | ||
| US5972912A (en) | Method for lyophilizing ifosfamide | |
| KR20130008011A (ko) | 인간 ⅸ 인자 서방형 제제 | |
| HK1205685B (en) | Lyophilization of synthetic liposomal pulmonary surfactant | |
| JP5265514B2 (ja) | Ｈｇｆ製剤 | |
| JP3899694B2 (ja) | 凍結乾燥法 | |
| CN116685309A (zh) | 改善的冻干制剂 | |
| JPS61137828A (ja) | γ−インタ−フエロン製剤組成物 |